PortfoliosLab logoPortfoliosLab logo
Hinge Health, Inc (HNGE)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US4333131039
IPO Date
May 22, 2025

Highlights

Market Cap
$3.26B
Enterprise Value
$3.06B
EPS (TTM)
-$6.56
Total Revenue (TTM)
$587.86M
Gross Profit (TTM)
$468.22M
EBITDA (TTM)
-$528.31M
Year Range
$30.08 - $62.18
Target Price
$56.78
ROA (TTM)
-70.93%
ROE (TTM)
-295.68%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Hinge Health, Inc

Often compared with HNGE:
HNGE vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Hinge Health, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period


Hinge Health, Inc

1D
4.87%
1M
-9.82%
YTD
-16.99%
6M
-21.43%
1Y
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since May 22, 2025, HNGE's average daily return is +0.10%, while the average monthly return is +1.66%. At this rate, your investment would double in approximately 3.5 years.

Historically, 45% of months were positive and 55% were negative. The best month was Jun 2025 with a return of +33.2%, while the worst month was Jan 2026 at -24.9%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 3 months.

On a daily basis, HNGE closed higher 48% of trading days. The best single day was Aug 6, 2025 with a return of +25.6%, while the worst single day was Nov 5, 2025 at -15.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-24.87%22.52%-9.82%-16.99%
20253.41%33.24%-13.14%24.76%-12.48%1.39%-1.71%-5.03%23.67%

Benchmark Metrics

Hinge Health, Inc has an annualized alpha of 5.04%, beta of 1.42, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since May 23, 2025.

  • This stock tended to rise when S&P 500 Index fell (downside capture of -97.33%), but participation in market rallies was also limited (-10.91%) — a profile typical of counter-cyclical assets.
  • R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
5.04%
Beta
1.42
0.07
Upside Capture
-10.91%
Downside Capture
-97.33%

Return for Risk

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Hinge Health, Inc (HNGE) and compare them to a chosen benchmark (S&P 500 Index).


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Dividends

Dividend History


Hinge Health, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Hinge Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hinge Health, Inc was 48.52%, occurring on Feb 6, 2026. The portfolio has not yet recovered.

The current Hinge Health, Inc drawdown is 36.32%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-48.52%Aug 7, 2025127Feb 6, 2026
-17.28%May 28, 202513Jun 13, 20255Jun 23, 202518
-16.77%Jul 1, 20254Jul 7, 202522Aug 6, 202526
-5.09%Jun 25, 20251Jun 25, 20253Jun 30, 20254

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hinge Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Hinge Health, Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HNGE relative to other companies in the Health Information Services industry. Currently, HNGE has a P/S ratio of 5.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items